FMP
Global WholeHealth Partners Corporation
GWHP
PNK
Inactive Equity
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
0.0001 USD
-0.0001 (-100%)
About
ceo
Mr. F. Rene Alvarez Jr.
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://gwhpcorp.com
exchange
PNK
Description
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
CIK
0001598308
ISIN
US37959N1028
CUSIP
37959N102
Address
1402 North El Camino Real
Phone
714 392 9752
Country
US
Employee
N/A
IPO Date
Apr 9, 2015
Key Executives
